Table 1.

Multivariate analysis for outcome by KDR copy gain in NSCLC patients by adjuvant chemotherapy

CasesNComparisonOutcomeAdjusted HRa (95% CI)P
All patients115Gain vs. no gainOS4.00 (1.76–9.07)0.001
RFS1.83 (1.02–3.29)0.044
Adjuvant therapy61Gain vs. no gainOS5.16 (1.75–15.2)0.003
RFS1.87 (0.9–3.92)0.1
No adjuvant therapy54Gain vs. no gainOS1.99 (0.47–8.4)0.349
RFS1.83 (0.66–5.05)0.243
  • aAdjusting for tumor stage; follow-up is censored at 5 years.